Patents by Inventor Anna Kletzmayr

Anna Kletzmayr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION
    Publication number: 20240390398
    Abstract: Provided herein is an inositol polyphosphate oligo alkyl ether compound, or its pharmaceutically acceptable salt, for use in treatment or prevention of a disease associated with formation of calcium salt crystals.
    Type: Application
    Filed: July 30, 2024
    Publication date: November 28, 2024
    Applicants: ETH Zurich, Universitat Bern
    Inventors: Anna Kletzmayr, Makoto Kuro-o, Hirosaka Hayashi, Mattias Ivarsson, Jean-Christophe Leroux
  • CALCIUM OXALATE CRYSTALLIZATION INHIBITORS FOR RENAL DISORDERS
    Publication number: 20240336640
    Abstract: The present invention relates to inositol derivatives comprising two or more cyclohexanolpentakisester moieties linked by a common central linker and their use in therapy or prevention of a condition related to pathological crystallization. The invention further relates to useful intermediates in the synthesis of the compound of the invention.
    Type: Application
    Filed: June 16, 2024
    Publication date: October 10, 2024
    Applicant: VIFOR (INTERNATIONAL) AG
    Inventors: Mattias Emanuel IVARSSON, Jean-Christophe LEROUX, Anna KLETZMAYR
  • Inositol derivatives for use in pathological crystallization
    Patent number: 12076331
    Abstract: Provided herein is an inositol polyphosphate oligo alkyl ether compound, or its pharmaceutically acceptable salt, for use in treatment or prevention of a disease associated with formation of calcium salt crystals.
    Type: Grant
    Filed: June 12, 2023
    Date of Patent: September 3, 2024
    Assignees: ETH Zurich, Universitat Bern
    Inventors: Anna Kletzmayr, Makoto Kuro-o, Hirosaka Hayashi, Mattias Ivarsson, Jean-Christophe Leroux
  • INOSITOL HEXAKISPHOSPHATE ANALOGUES FOR TREATMENT OF CALCIFICATION ASSOCIATED KIDNEY DISEASES
    Publication number: 20240000811
    Abstract: The invention is related to an inositol polyphosphate oligo alkyl ether compound, or its pharmaceutically acceptable salt, for use in treatment or prevention of a disease associated with formation of calcium salt crystals.
    Type: Application
    Filed: November 19, 2021
    Publication date: January 4, 2024
    Applicants: VIFOR (INTERNATIONAL) AG, ETH ZÜRICH
    Inventors: Mattias Emanuel IVARSSON, Jean-Christophe LEROUX, Anna KLETZMAYR, Makoto KURO-O, Hirosaka HAYASHI
  • INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION
    Publication number: 20230338401
    Abstract: Provided herein is an inositol polyphosphate oligo alkyl ether compound, or its pharmaceutically acceptable salt, for use in treatment or prevention of a disease associated with formation of calcium salt crystals.
    Type: Application
    Filed: June 12, 2023
    Publication date: October 26, 2023
    Applicants: ETH Zurich, Universitat Bern
    Inventors: Anna Kletzmayr, Makoto Kuro-o, Hirosaka Hayashi, Mattias Ivarsson, Jean-Christophe Leroux
  • Inositol derivatives for use in pathological crystallization
    Patent number: 11707470
    Abstract: The invention is related to an inositol polyphosphate oligo alkyl ether compound, or its pharmaceutically acceptable salt, for use in treatment or prevention of a disease associated with formation of calcium salt crystals.
    Type: Grant
    Filed: June 7, 2021
    Date of Patent: July 25, 2023
    Assignees: ETH Zurich, Universitat Bern
    Inventors: Anna Kletzmayr, Makoto Kuro-o, Hirosaka Hayashi, Mattias E. Ivarsson, Jean-Christophe Leroux
  • CALCIUM OXALATE CRYSTALLIZATION INHIBITORS FOR RENAL DISORDERS
    Publication number: 20210347793
    Abstract: The present invention relates to inositol derivatives comprising two or more cyclohexanolpentakisester moieties linked by a common central linker and their use in therapy or prevention of a condition related to pathological crystallization. The invention further relates to useful intermediates in the synthesis of the compound of the invention.
    Type: Application
    Filed: September 18, 2019
    Publication date: November 11, 2021
    Applicant: INOSITEC AG
    Inventors: Mattias Emanuel IVARSSON, Jean-Christophe LEROUX, Anna KLETZMAYR
  • INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION
    Publication number: 20210290643
    Abstract: The invention is related to an inositol polyphosphate oligo alkyl ether compound, or its pharmaceutically acceptable salt, for use in treatment or prevention of a disease associated with formation of calcium salt crystals.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Applicants: ETH Zurich, INOSITEC AG
    Inventors: Anna Kletzmayr, Makoto Kuro-o, Hirosaka Hayashi, Mattias E. Ivarsson, Jean-Christophe Leroux